INTRODUCTION
============

Diagnosis and management of sepsis has been an Achilles heel in any form of clinical practice. The aim in management of patients with sepsis is to recognize and treat them at an early stage so that its consequences can be prevented. To better define sepsis a consensus panel that included representatives from the American College of Chest Physicians and Society of Critical Care Medicine gave its recommendations in 1991 \[[@B1]\]. The definitions included that of systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis and septic shock. These definitions were revised and expanded by another consensus panel in 2001 \[[@B2]\]. The most recent update to the definition of sepsis has been done by the Sepsis-3 task force in 2016 \[[@B3]\]. They defined sepsis as 'life threatening organ dysfunction caused by a dysregulated host response to infection'. They recommended the use of sequential (sepsis-related) organ failure assessment (Sequential Organ Failure Assessment, SOFA) as a measure of organ dysfunction. As the SOFA score is not universally accessible (especially for PaO~2~ which requires blood gas measurement), in addition they proposed the quick SOFA or quick Sequential Organ Failure Assessment (qSOFA) to rapidly assess the patient clinically for risk of deterioration due to sepsis, at bedside in wards or the emergency department outside the intensive care unit (ICU) \[[@B3]\].

Up to 30% of patients with sepsis have a urologic cause for sepsis (uro-sepsis) and the main reason for this is obstruction of the urinary tract \[[@B4][@B5][@B6]\]. Uro-sepsis (acute pyelonephritis, APN) due to obstructive upper urinary tract calculi is commonly encountered in urologic practice. In addition to antibiotics and other supportive measures it usually requires relief of obstruction with the help of a nephrostomy or a double J (JJ)-stent \[[@B7][@B8]\]. Many times this disease requires management in an ICU and the mortality rate in literature has been reported to be as high as 10% \[[@B7][@B9][@B10]\].

The qSOFA score has been an area of great debates, especially its utility in predicting in-hospital mortality. Some authors found qSOFA to have a better prognostic accuracy and others have reported SIRS criteria as described previously, to be more accurate than qSOFA in predicting in-hospital mortality \[[@B11][@B12][@B13]\]. We thus conducted this study to assess the utility of qSOFA in patients with uro-sepsis due to APN with upper urinary tract calculi.

MATERIALS AND METHODS
=====================

We retrospectively reviewed our prospectively maintained database for patients who were admitted and treated for APN with upper urinary tract calculi between January 2015 and June 2018. The Institutional Review Board of King George\'s Medical University approved the study (approval number: 2981/Ethics/R-cell-18). Informed consent was taken from the patient. We could identify 162 such patients and thoroughly reviewed their medical records. In patients with multiple admissions for this disease we included the most severe episode. The patients with APN due to other causes including surgical interventions and those with bilateral APN were excluded from the study.

The diagnosis of APN was made on basis of clinical examination that included flank pain, tenderness and fever along with raised total leucocyte counts (TLC), C-reactive protein, urine analysis and culture. The presence of upper urinary tract calculi was confirmed on ultrasonography (USG) and plain X-ray of kidney-ureter-bladder. In case of doubt a non-contrast computed tomography scan was done. We included patients both with obstructive and non-obstructive calculi. The patients were treated with antibiotics and other supportive measures. When decompression of the collecting system was required, either a double J-stent or USG guided per-cutaneous nephrostomy (PCN) was placed.

We collected the patient data that included their age, gender, Eastern Cooperative Oncology Group performance status (ECOG-PS), Charlson comorbidity index (CCI), body mass index (BMI), respiratory rate, body temperature, pulse rate, blood pressure, Glasgow Coma Scale (GCS), method of drainage, ICU admission and mortality. Mortality and ICU admissions were our primary and secondary outcomes respectively.

To calculate SIRS and qSOFA we used the worst physiological and laboratory data within the first 24 hours of admission. The criteria for SIRS included a temperature of \>38℃ or \<36℃, pulse rate \>90 per minute, respiratory rate \>20 breaths per minute and a TLC \>12,000 or \<4,000/mm^3^ or \>10% immature forms (bands) \[[@B1]\]. For qSOFA the criteria included respiratory rate \>22 breaths per minute, systolic blood pressure \<100 mmHg and altered mental status with GCS \<15 \[[@B3]\].

Statistical analysis was done using IBM SPSS Statistics ver. 21.0 software (IBM Co., Armonk, NY, USA). Continuous data was represented as median with range and categorical data with percentage. Chi-square test was used for categorical data and student t-test for continuous data. A p-value \<0.05 was considered significant. For calculating the predictors of in-hospital mortality and ICU admissions, those clinical characteristics with more than 10 occurrences were analyzed in a univariate model. The significant variables were combined in a multivariate logistic regression analysis model. The accuracy of SIRS and qSOFA in predicting in-hospital mortality and ICU admissions was calculated using area under curve (AUC) of the receiver operating characteristic (ROC) curve. The optimal cut off and sensitivity and specificity for qSOFA and SIRS was determined using co-ordinates of the ROC curve.

RESULTS
=======

The median age of the study population was 42 years (range, 18--70 years) out of which 86 patients (53.1%) were females. The median BMI was 21 kg/m^2^ ((range, 16 to 32 kg/m^2^) and 35 patients (21.6%) had a BMI of more than 25 kg/m^2^. There were 14 patients (8.6%) with an ECOG-PS of greater than 2. The most common associated comorbidity was diabetes mellitus (DM), which was present in 60 patients (37.0%) followed by hypertension, which was present in 27 patients (16.7%). Seventy-one patients (43.8%) had a CCI of greater than 2. Right-sided APN was present in 74 patients (45.7%) and 88 patients (54.3%) had left sided disease. The most common method of drainage was PCN placement, which was done in 75 (46.3% patients). A double J-stent was placed in 65 patients (40.1%) and rest, were managed conservatively. The characteristics are summarized in [Table 1](#T1){ref-type="table"}.

A qSOFA score of ≥2 was present in 14.2% patients whereas a SIRS score of ≥2 was present in 92.6% patients. Eighty two percent patients with qSOFA ≥2 and 84.7% patients with SIRS ≥2 underwent drainage of the pelvicalyceal system. A greater proportion of patients (52.0%) with qSOFA of ≥2 underwent drainage by PCN placement as compared to patients with SIRS ≥2 (44.7%). The overall mortality rate and ICU admission rates were 7.4% and 12.9%, respectively. The association of various clinical characteristics with in-hospital mortality and ICU admissions is given in [Tables 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}. Patients with a higher qSOFA had a highly significant (p\<0.001) rate of inhospital mortality and ICU admissions. The distribution of in-hospital mortality and ICU admissions according to the qSOFA score is give in [Figs. 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}.

The predictive accuracy of qSOFA (AUC, 0.981; 95% confidence interval \[CI\], 0.962--1.000) for in-hospital mortality was higher than that of SIRS (AUC, 0.924; 95% CI, 0.860--0.989). Similarly for ICU admissions qSOFA (AUC, 0.977; 95% CI, 0.955--0.999) had a higher predictive accuracy than SIRS (AUC, 0.860; 95% CI, 0.792--0.928). A qSOFA score of ≥2 had a sensitivity and specificity of 100% and 93% respectively for in-hospital mortality and 90% and 97% for ICU admissions, whereas the same for SIRS ≥2 was 100% and 66% for inhospital mortality and 100% and 63% for ICU admissions. The ROC curves of SIRS and qSOFA are depicted in [Fig. 3](#F3){ref-type="fig"}. The predictive value of qSOFA ≥2 in a multivariate logistic regression model is given in [Table 4](#T4){ref-type="table"}.

DISCUSSION
==========

Although the qSOFA score as recommended by the Sepsis-3 task is an easy bedside tool for assessing the prognosis of patients with sepsis, its prognostic accuracy has remained an area of debate. The SOFA score is a better measure of outcome in patients with sepsis than qSOFA and SIRS, but usually it is more relevant in an ICU setting as it requires a number of laboratory tests and clinical parameters. This led to the recommendation of using the qSOFA score, which is rapid and more relevant in the ward setting especially when there are limited resources \[[@B3][@B13]\]. The qSOFA score has found to have a low sensitivity for identifying patients with sepsis, which is a major limitation to its utility \[[@B14][@B15]\]. One study also found it to have a low sensitivity of predicting mortality due to sepsis \[[@B15]\]. When compared to the SIRS score, the qSOFA score has a lower sensitivity but higher specificity for predicting mortality in patients with sepsis \[[@B16][@B17]\]. The general consensus is that SIRS is too sensitive to predict outcomes in patients with sepsis and thus the requirement of better scores.

A fair argument may be that severe sepsis is more specific in predicting ICU admissions and mortality in patients with sepsis. This has also been proven in previous studies \[[@B18]\]. But evaluating all elements to diagnose patients with severe sepsis may not be possible in non-ICU settings, especially in rural areas or centers with constraint of resources (which is also the case with SOFA score as mentioned vide supra). The assessments of mental status and blood pressure in qSOFA score are also parameters used to assess severe sepsis \[[@B1]\]. Being a retrospective study we could not compare qSOFA and severe sepsis, but it would be reasonable to say that due to its simplicity qSOFA would be a better predictor of ICU admissions and mortality than both SIRS and severe sepsis.

Treating patients with uro-sepsis is an integral part of urologic practice and it is pertinent that a urologist is aware and up to-date with the various tools in assessing patients with sepsis. Our study found qSOFA score to be a very useful tool in predicting the outcome of patients with urosepsis because of APN with upper urinary tract calculi. The specificity and predictive accuracy of qSOFA score were found to be higher than the SIRS score. A qSOFA score of ≥2 was found to be an optimum cut off for predicting the inhospital mortality and ICU admissions. This would improve the patient management as those with higher qSOFA can be transferred to the ICUs earlier with aggressive management improving the outcome of these patients.

qSOFA is calculated purely on clinical parameters and no laboratory tests are required in its calculation unlike SIRS. According to one study the altered mental state used to assess qSOFA had a higher odds ratio to predict inhospital mortality and this explains the higher predictive performance of qSOFA over SIRS \[[@B6]\]. Literature on the utility of these new scores in patients with urologic cause of sepsis is lacking and our study could be a valuable addition to that.

Our study has certain important limitations. Firstly, it is a retrospective study with a limited sample size carried out in a single institute. A larger, multi-institutional prospective study would better validate the utility of qSOFA as a rapid bedside assessment tool in this cohort of patients. Secondly, we could not analyze the SOFA score as it requires a host of clinical and laboratory parameters which were not available for all patients. Thirdly, our institute is a state run tertiary care center in Northern India, which mainly caters to patients from rural areas with lower socio-economic status and thus our data is more pertinent to that subset of patient population.

CONCLUSIONS
===========

The role of qSOFA as proposed by the Sepsis-3 task force, as a rapid bedside assessment tool in patients with sepsis replacing the SIRS score has been a matter of debate in recent literature. Our study finds qSOFA to be better tool than SIRS having a high predictive accuracy in predicting in-hospital mortality and ICU admission in patients with uro-sepsis because of APN due to upper urinary tract calculi.
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###### Characteristics of the study population
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  Characteristic           Value
  ------------------------ ------------------------
  Total patients           162 (100.0)
  Age (y)                  42 (18--70)
  Sex                      
   Male                    76 (46.9)
   Female                  86 (53.1)
  ECOG PS \>2              14 (8.6)
  BMI (kg/m^2^)            21 (16--32)
   BMI, \>25 kg/m^2^       35 (21.6)
  Co-morbidities           
   Diabetes mellitus       60 (37.0)
   Hypertension            27 (16.7)
   Immunosuppression       16 (9.9)
   Stroke                  3 (1.8)
   Myocardial infarction   4 (2.5)
   Malignancy              8 (4.9)
  CCI ≥2                   71 (43.8)
  Laterality of APN        
   Right                   74 (45.7)
   Left                    88 (54.3)
  Method of drainage       
   PCN                     75 (46.3)
   Double J-stent          65 (40.1)
   Conservative            22 (13.6)
  TLC (/mm^3^)             12,200 (1,400--27,700)
  qSOFA                    0 (0--3)
   qSOFA 0--1              140 (86.4)
   qSOFA ≥2                23 (14.2)
  SIRS                     3 (0--4)
   SIRS 0--1               12 (7.4)
   SIRS ≥2                 150 (92.6)

Values are presented as number (%) or median (range).

ECOG PS, Eastern Cooperative Oncology Group performance status; BMI, body mass index; CCI, Charlson comorbidity index; APN, acute pyelonephritis; PCN, per-cutaneous nephrostomy; TLC, total leucocyte counts; qSOFA, quick Sequential Organ Failure Assessment; SIRS, systemic inflammatory response syndrome.

###### Comparison of clinical characteristics in patients with and without mortality
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  Characteristic       No mortality             Mortality                 p-value
  -------------------- ------------------------ ------------------------- ---------
  Total patients       150 (100.0)              12 (100.0)                \-
  Age (y)              42.5 (18--70)            49 (40--68)               0.005
  Sex                                                                     0.824
   Male                70 (46.7)                6 (50.0)                  
   Female              80 (53.3)                6 (50.0)                  
  ECOG PS \>2          6 (4.0)                  6 (50.0)                  \<0.001
  BMI (kg/m^2^)        21 (16--32)              21.25 (17--30)            0.829
   BMI, \>25 kg/m^2^   32 (21.3)                3 (25.0)                  0.766
  Co-morbidities                                                          
   Diabetes mellitus   50 (33.3)                10 (83.3)                 0.001
   Hypertension        23 (15.3)                4 (33.3)                  0.107
   Immunosuppression   12 (8.0)                 4 (33.3)                  0.005
  CCI \>2              61 (40.7)                9 (75.0)                  0.024
  Method of drainage                                                      0.059
   PCN                 67 (44.7)                8 (66.7)                  
   Double J-stent      64 (42.7)                1 (8.3)                   
   Conservative        19 (12.7)                3 (25.0)                  
  TLC (/mm^3^)         12,200 (1,400--27,700)   13,850 (10,200--18,900)   0.010
  qSOFA                0 (0--3)                 2.5 (2--3)                \<0.001
   qSOFA 0--1          139 (92.7)               0 (0.0)                   \<0.001
   qSOFA ≥2            11 (7.3)                 12 (100.0)                
  SIRS                 2 (0--4)                 4 (3--4)                  \<0.001
   SIRS 0--1           13 (8.7)                 0 (0.0)                   0.288
   SIRS ≥2             137 (91.3)               12 (100.0)                

Values are presented as number (%) or median (range).

ECOG PS, Eastern Cooperative Oncology Group performance status; BMI, body mass index; CCI, Charlson comorbidity index; PCN, per-cutaneous nephrostomy; TLC, total leucocyte counts; qSOFA, quick Sequential Organ Failure Assessment; SIRS, systemic inflammatory response syndrome.

###### Comparison of clinical characteristics in patients with and without ICU admissions
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                       No ICU admission         ICU admission            p-value
  -------------------- ------------------------ ------------------------ ---------
  Total patients       141 (100.0)              21 (100.0)               
  Age (y)              40 (18--70)              49 (21--65)              0.018
  Sex                                                                    0.945
   Male                66 (46.8)                10 (47.6)                
   Female              75 (53.2)                11 (52.4)                
  ECOG PS \>2          3 (2.1)                  11 (52.4)                \<0.001
  BMI (kg/m^2^)        21 (16--32)              20 (17.5--30)            0.698
   BMI, \>25 kg/m^2^   30 (21.3)                5 (23.8)                 0.792
  Co-morbidities                                                         
   Diabetes mellitus   46 (32.6)                14 (66.7)                0.003
   Hypertension        20 (14.2)                7 (33.3)                 0.028
   Immunosuppression   8 (5.7)                  8 (38.1)                 \<0.001
  CCI \>2              52 (36.9)                19 (90.5)                \<0.001
  Method of drainage                                                     0.841
   PCN                 65 (46.1)                10 (47.6)                
   Double J-stent      56 (39.7)                9 (42.9)                 
   Conservative        20 (14.2)                2 (9.5)                  
  TLC (/mm^3^)         12,200 (1,400--27,700)   11,200 (4,200--20,200)   0.627
  qSOFA                0 (0--2)                 2 (1--3)                 \<0.001
   qSOFA 0--1          137 (97.2)               2 (9.5)                  \<0.001
   qSOFA ≥2            4 (2.8)                  19 (90.5)                
  SIRS                 2 (0--4)                 3 (3--4)                 \<0.001
   SIRS 0--1           13 (9.2)                 0 (0.0)                  0.147
   SIRS ≥2             128 (90.8)               21 (100.0)               

Values are presented as number (%) or median (range).

ICU, intensive care unit; ECOG PS, Eastern Cooperative Oncology Group performance status; BMI, body mass index; CCI, Charlson comorbidity index; PCN, per-cutaneous nephrostomy; TLC, total leucocyte counts; qSOFA, quick Sequential Organ Failure Assessment; SIRS, systemic inflammatory response syndrome.

###### Multivariate logistic regression analysis of predictors of in-hospital mortality and ICU admissions
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  Variable        OR       95% CI              p-value
  --------------- -------- ------------------- ---------
  Mortality                                    
   qSOFA          40.03    1.734--924.225      0.021
  ICU Admission                                
   qSOFA          163.64   11.719--2,285.140   0.003

ICU, intensive care unit; OR, odds ratio; CI, confidence interval; qSOFA, quick Sequential Organ Failure Assessment.
